IBM Sells Watson Health to Private Investment Company
Francisco Partners is acquiring healthcare data and analytics assets from IBM.
Tag Archives: artificial intelligence
Cybersecurity Attacks Once Again Top ECRI’s Annual Health Technology Hazards List
The threat of an attack is imminent. It is critical for medical devices and systems, as well as healthcare facilities to have the right safeguards in place.
The Power of Artificial Intelligence in the Medical Field
Opportunities for intelligent computer systems span widely, including extensive use in medical science. Artificial intelligence enhances cognition analysis of complex health issues and improves the diagnoses. However, there are still some challenges in terms of data quality, regulations, market penetration and adaptation.
The Role of AI Technology in Cancer Detection, Diagnosis and Treatment
On the cusp of artificial intelligence (AI) becoming a ubiquitous feature of our everyday lives, researchers discover that intelligent systems thinking offers a wealth of potential applications in the fight against a cunning human adversary: Cancer.
Biopharma and Medical Device Trends Investors Should Watch in 2022
For private equity and venture capital investors alike, there are five key trends presenting both headwinds and tailwinds that may impact investment flows into 2022.
The Growing Role of Artificial Intelligence in Telehealth
The application of AI in telehealth to allow doctors to make real-time, data-driven rich choices is a key component in generating a better patient experience and improved health outcomes.
AI/ML-based SaMD: Trends in Litigation
This pioneering area of technology comes with new risks and questions of liability.
Medical Device Manufacturing: Five Challenges in Maintaining Compliance
The industry struggles with various unknowns that impact efficiency, quality, and as a result, finances. This article reviews some of these challenges and how to overcome them.
EU MDR Compliance: Do Your CERs and PERs Hit the Regulatory Bar?
MedTech Intelligence recently sat down with Peter O‘Blenis, CEO of Evidence Partners to discuss challenges reviewers face throughout their literature review process in the context of regulatory compliance, and to talk about the upcoming virtual event, Evidence Matters 2021.
Diagnostic and Monitoring Solutions Define Smart MedTech Industry Trends
Increased awareness during the COVID-19 crisis and public efforts to strengthen the development of healthcare technologies has boosted the smart medical devices sector.
